Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRVS | RVNC | XOMA | ||
| Company | Corvus Pharma Com | Revance Therapeutics | Xoma Royalty Corporation | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.02 | 3.07 | 24.88 | ||
| High | 5.34 | 3.09 | 27.49 | ||
| Low | 4.73 | 3.07 | 24.54 | ||
| Last | 4.99 | 3.09 | 27.13 | ||
| Change | -0.10 | +0.02 | +2.02 | ||
| % Change | -1.96% | +0.65% | +8.04% | ||
| Volume | 2,585,800 | 3,458,700 | 132,100 | ||
| 20-Day Average Volume | 1,642,340 | 3,648,075 | 38,160 | ||
| Previous Close | 5.09 | 3.07 | 25.11 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.74 | 3.46 | 29.73 | ||
| 20-Day Raw Stochastic | 21.11% | 6.67% | 24.76% | ||
| 20-Day Relative Strength | 32.75% | 35.03% | 42.82% | ||
| Weighted Alpha | +158.97 | -72.19 | +32.92 | ||
| Today's Opinion | 24% Buy | 80% Sell | 8% Buy | ||
| Previous Opinion | 24% Buy | 56% Sell | 8% Buy | ||
| Last Month's Opinion | 80% Buy | 24% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -32.38% since 12/13/24 | +0.32% since 12/13/24 | -0.07% since 12/13/24 | ||
| Low | 3.77 on 12/18/24 | 3.06 on 12/17/24 | 24.54 on 12/20/24 | ||
| High | 7.44 on 12/17/24 | 3.09 on 12/19/24 | 28.14 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | -39.44% since 11/20/24 | -18.68% since 11/20/24 | -9.63% since 11/20/24 | ||
| Low | 3.77 on 12/18/24 | 3.01 on 12/09/24 | 24.54 on 12/20/24 | ||
| High | 9.55 on 11/29/24 | 4.21 on 11/27/24 | 35.00 on 11/27/24 | ||
| 3-Month | |||||
| %Chg | -15.57% since 09/20/24 | -46.82% since 09/20/24 | -3.76% since 09/20/24 | ||
| Low | 3.77 on 12/18/24 | 3.01 on 12/09/24 | 24.54 on 12/20/24 | ||
| High | 10.00 on 11/13/24 | 6.09 on 10/28/24 | 35.00 on 11/27/24 | ||
| 6-Month | |||||
| %Chg | +161.26% since 06/20/24 | +7.67% since 06/20/24 | +5.16% since 06/20/24 | ||
| Low | 1.75 on 07/05/24 | 2.30 on 06/26/24 | 21.86 on 06/26/24 | ||
| High | 10.00 on 11/13/24 | 6.65 on 08/19/24 | 35.00 on 11/27/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 320,642 | 322,565 | 319,673 | ||
| Shares Outstanding, K | 64,257 | 104,390 | 11,783 | ||
| Annual Sales | 0 | 234,040,000 | 4,760,000 | ||
| Annual Net Income | -27,030,000 | -323,990,000 | -40,830,000 | ||
| Last Quarter Sales | 0 | 59,880,000 | 7,200,000 | ||
| Last Quarter Net Income | -40,220,000 | -38,120,000 | -17,240,000 | ||
| 60-Month Beta | 1.05 | 0.81 | 0.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 11/12/24 | -0.37 on 11/07/24 | -0.39 on 11/07/24 | ||
| Latest Earnings Date | 11/12/24 | 11/13/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||